Clinical Trials Update: July 27, 2005
Colorectal Cancer Allergy (Pediatric) Healthy Patient Studies
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This study is for patients who have cancer of the colon or rectum that has spread to the liver and cannot be removed by surgery because of its size or location. The purpose of this study is to see if the chemotherapy treatment Folfiri plus bevacizumab can decrease the size of the cancer in one's liver so that any tumor remaining can be completely removed with surgery. You may be eligible to participate if you are 18 or older and have cancer of the colon or rectum that has spread to the liver, but not to other organs, which cannot be removed by surgery. Research site located in New York, NY.
Health Sciences Research Center is conducting a research study to evaluate an investigational drug for children 6 to 11 years of age. The patients in this study must have moderate-to-severe asthma and continue to demonstrate inadequate control. You may participate if you are six to 11 years old, have moderate-to-severe persistent asthma for at least one year, have inadequate symptom control of asthma and have a past medical history of asthma exacerbations requiring more medication or treatment in a hospital or emergency room. Research site located in Ithaca, NY.
Healthy Patient Studies
This study seeks healthy volunteers between the ages of 18-60, who have no family history of diabetes, to participate in research studies at the Joslin Diabetes Center and Brigham and Women's Hospital. People with a family history of diabetes are at greater risk of developing the disease. Your participation will help us to better understand the disease and could lead to new treatment options for people with type 2 diabetes. Research site located in Boston, Mass.
Copyright 2005 CenterWatch. All rights reserved.